| Dr Gerald Marc Segal, MD | |
|
265 N Broadway St, Portland, OR 97227-1800 | |
| (503) 280-1223 | |
| (503) 528-5252 |
| Full Name | Dr Gerald Marc Segal |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 45 Years |
| Location | 265 N Broadway St, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942203534 | NPI | - | NPPES |
| 171454 | Medicaid | OR | |
| 1022695 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD14774 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Legacy Good Samaritan Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Cancer Specialists Pc | 8426943838 | 61 |
| Northwest Cancer Specialists Pc | 8426943838 | 61 |
News Archive
The Institute for OneWorld Health (iOWH) announced a major milestone in the fight against cholera. The Food and Drug Administration (FDA) granted iOWH permission to begin phase 1 trials for iOWH032, a drug to treat secretory diarrhea. This is the first submission of an Investigational New Drug application for a completely new chemical entity by a non-profit of this size to receive such rapid FDA clearance, and it could be the first synthetic drug of its kind for diarrheal diseases.
CQ looks forward and offer analyses regarding how determinations about mandatory and discretionary spending will impact the health law's implementation. Meanwhile, Modern Healthcare reports on a new study exploring how central the individual insurance mandate is to expanding coverage.
A new study out today suggests that tuna or broiled/baked fish lowers the risk of an irregular hearbeat among elderly people.
Studies reporting the results of industry sponsored clinical trials present a more favourable picture of the effects of drugs and medical devices than those reporting on non-industry sponsored trials, according to a new Cochrane systematic review. The researchers call for a rethink of the way that industry bias is handled in medical guidelines and reviews.
Gov. Chris Christie said he would propose an overhaul to the state's pension and health benefits system later this summer, revisiting an issue that burnished his national political image in 2011 but challenged him this spring when he scaled back promised funding. As the governor signed a $32.5 billion budget on Monday, he vetoed tax increases designed to offset pension costs and called changing the pension and benefits system his main economic priority for 2014 (Dawsey and Haddon, 6/30).
› Verified 8 days ago
| Entity Name | Northwest Cancer Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407828114 PECOS PAC ID: 8426943838 Enrollment ID: O20040217000848 |
News Archive
The Institute for OneWorld Health (iOWH) announced a major milestone in the fight against cholera. The Food and Drug Administration (FDA) granted iOWH permission to begin phase 1 trials for iOWH032, a drug to treat secretory diarrhea. This is the first submission of an Investigational New Drug application for a completely new chemical entity by a non-profit of this size to receive such rapid FDA clearance, and it could be the first synthetic drug of its kind for diarrheal diseases.
CQ looks forward and offer analyses regarding how determinations about mandatory and discretionary spending will impact the health law's implementation. Meanwhile, Modern Healthcare reports on a new study exploring how central the individual insurance mandate is to expanding coverage.
A new study out today suggests that tuna or broiled/baked fish lowers the risk of an irregular hearbeat among elderly people.
Studies reporting the results of industry sponsored clinical trials present a more favourable picture of the effects of drugs and medical devices than those reporting on non-industry sponsored trials, according to a new Cochrane systematic review. The researchers call for a rethink of the way that industry bias is handled in medical guidelines and reviews.
Gov. Chris Christie said he would propose an overhaul to the state's pension and health benefits system later this summer, revisiting an issue that burnished his national political image in 2011 but challenged him this spring when he scaled back promised funding. As the governor signed a $32.5 billion budget on Monday, he vetoed tax increases designed to offset pension costs and called changing the pension and benefits system his main economic priority for 2014 (Dawsey and Haddon, 6/30).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gerald Marc Segal, MD 265 N Broadway St, Portland, OR 97227-1800 Ph: (503) 280-1223 | Dr Gerald Marc Segal, MD 265 N Broadway St, Portland, OR 97227-1800 Ph: (503) 280-1223 |
News Archive
The Institute for OneWorld Health (iOWH) announced a major milestone in the fight against cholera. The Food and Drug Administration (FDA) granted iOWH permission to begin phase 1 trials for iOWH032, a drug to treat secretory diarrhea. This is the first submission of an Investigational New Drug application for a completely new chemical entity by a non-profit of this size to receive such rapid FDA clearance, and it could be the first synthetic drug of its kind for diarrheal diseases.
CQ looks forward and offer analyses regarding how determinations about mandatory and discretionary spending will impact the health law's implementation. Meanwhile, Modern Healthcare reports on a new study exploring how central the individual insurance mandate is to expanding coverage.
A new study out today suggests that tuna or broiled/baked fish lowers the risk of an irregular hearbeat among elderly people.
Studies reporting the results of industry sponsored clinical trials present a more favourable picture of the effects of drugs and medical devices than those reporting on non-industry sponsored trials, according to a new Cochrane systematic review. The researchers call for a rethink of the way that industry bias is handled in medical guidelines and reviews.
Gov. Chris Christie said he would propose an overhaul to the state's pension and health benefits system later this summer, revisiting an issue that burnished his national political image in 2011 but challenged him this spring when he scaled back promised funding. As the governor signed a $32.5 billion budget on Monday, he vetoed tax increases designed to offset pension costs and called changing the pension and benefits system his main economic priority for 2014 (Dawsey and Haddon, 6/30).
› Verified 8 days ago
Salona Shrestha, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |